3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
5
Papillomavirus Infections
4
Uterine Cervical Neoplasms
3
Uterine Cervical Dysplasia
3
Pancreatic Neoplasms
3
Neoplasms
3
Multiple Myeloma
3
Lymphoma, Follicular
3
Triple Negative Breast Neoplasms
2
Lymphoma, Mantle-Cell
2
Lymphoma
2
Lung Neoplasms
2
Waldenstrom Macroglobulinemia
1
Thymic aplasia
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Pneumonia
1
Osteosarcoma
1
Obesity
1
Neurofibromatosis 1
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Extranodal NK-T-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphohistiocytosis, Hemophagocytic
1
Interventions
Pemetrexed
12
Cisplatin
11
pembrolizumab
8
Carboplatin
6
Ipilimumab
5
Nivolumab
4
LMB-100
4
durvalumab
3
Gemcitabine
3
tremelimumab
2
tazemetostat
2
anetumab ravtansine
2
Vinorelbine
2
Plicamycin
2
Dexamethasone
2
Cyclophosphamide
2
Bevacizumab
2
vandetanib
1
tocilizumab
1
spartalizumab
1
ribociclib
1
rebastinib
1
pevonedistat
1
olaparib
1
niraparib
1
nintedanib
1
fludarabine phosphate
1
fludarabine
1
epacadostat
1
enzalutamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Mesothelioma
×
Blood Specimen Collection
×
Clear all
No trials found.